Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial AsthmaBusiness Wire • 10/05/20
U.S. federal appeals court reinstates GSK’s £182 million ruling against Teva PharmaceuticalInvezz • 10/04/20
Rosen, A Top Ranked Law Firm, Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVANewsfile Corp • 10/02/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Teva Pharmaceutical Industrial Limited (TEVA) on Behalf of InvestorsBusiness Wire • 10/01/20
Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020Business Wire • 10/01/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Teva Pharmaceutical Industrial Limited (TEVA) on Behalf of InvestorsBusiness Wire • 10/01/20
Teva Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva Pharmaceutical Industries Limited To Contact The FirmNewsfile Corp • 09/28/20
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 09/28/20
ROSEN, LEADING INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited; Encourages Investors with Losses in Excess of $100K to Contact the Firm - TEVAPRNewsWire • 09/25/20
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 09/24/20
TEVA EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited – TEVABusiness Wire • 09/24/20
Pomerantz Law Firm Announces the Filing of a Class Action against Teva Pharmaceuticals Industries Limited and Certain Officers - TEVAPRNewsWire • 09/24/20
Teva to Present New Data at The MDS Virtual Congress 2020 and Psych Congress 2020 Virtual Experience Evaluating Long-Term Treatment with AUSTEDO® (deutetrabenazine) TabletsBusiness Wire • 09/14/20
Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at the MDS Virtual Congress 2020 and Psych Congress 2020 Virtual ExperienceBusiness Wire • 09/08/20